Stocks
Dicerna Pharmaceuticals (DRNA) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 9 286% | 27 807% | 12 733% | 1 722% | 1 748% | 1 820% | |||
| Changes by years, y/y, % | +5 408pp | +18 521pp | -15 074pp | -11 011pp | +26pp | -14.7% | |||
Dicerna Pharmaceuticals. R&D/CAPEX, %
Dicerna Pharmaceuticals. R&D/CAPEX, changes, pp
Dicerna Pharmaceuticals (DRNA) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
| R&D/CAPEX, % | 1 325% | 1 270% | 1 659% | 1 158% | 360 188% | 1 820% | ||
| Changes by years, y/y, % | -738pp | -2 094pp | -1 469pp | -1 540pp | +358 863pp | |||
| Changes by quarters, q/q, % | -1 373pp | -55pp | +389pp | -501pp | +359 030pp | |||
